Molecular characterization of hepatitis B virus genotypes A and D among inmates and blood donors in Northeastern Kenya
Open Access
- 17 February 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0336726
Abstract
Introduction: Hepatitis B virus (HBV) persists as a major global public health burden, with hyperendemic prevalence in sub-Saharan Africa. Populations with elevated exposure to percutaneous transmission risks, including incarcerated individuals and healthcare workers demonstrate heightened HBV susceptibility. Despite this, genomic data from Northeastern Kenya and Kenyan prison populations remain scarce. Objective: To characterize HBV genotypic diversity circulating in Northeastern Kenya, among low-risk (blood donors) and high-risk (prison inmates) populations. Methods: A cross-sectional investigation compared HBV seroprevalence and genotypes between incarcerated individuals (n = 130) and voluntary blood donors (n = 130) in Garissa County, Northeastern Kenya. Serum samples were subjected to Hepatitis B surface antigen (HBsAg) screening, PCR amplification of a 940-bp overlapping surface/polymerase gene, sequencing, and phylogenetic/recombination analyses of the resulting sequences. Results: Seroprevalence was higher among incarcerated individuals (5.4%, 7/130) than blood donors (3.1%, 4/130). Hepatitis B Virus DNA was detected in 22 samples which were all successfully sequenced. Genotype D dominated both cohorts (81.8%), while genotype A sub genotype A1 occurred exclusively in incarcerated participants (18.2%). All genotype D strains were recombinants: D/A (61%) and D/E (39%). Sequences are accessible in GenBank (accession numbers: PV816552–PV816573). Conclusions: This first genomic study of HBV in Kenyan prisons confirms incarcerated populations as high-risk. The predominance of genotype D—an unusual finding in this region and high recombinant frequency (100% of genotype D strains) underscore significant viral evolution. Expanded genomic surveillance is imperative to define HBV diversity, inform vaccine efficacy monitoring, guide screening policies and optimize control strategies in Northeastern Kenya.Keywords
This publication has 37 references indexed in Scilit:
- A review of epidemiology and clinical relevance of Hepatitis B virus genotypes and subgenotypesClinics and Research in Hepatology and Gastroenterology, 2023
- Hepatitis B virus genetic multiplicity and the associated HBV lamivudine resistance mutations in HBV/HIV co-infection in Western Kenya: A review articleInfection, Genetics and Evolution, 2022
- Epidemiology and Treatment of Hepatitis B in PrisonersCurrent Hepatology Reports, 2017
- Identification and comparative analysis of hepatitis B virus genotype D/E recombinants in AfricaVirus Genes, 2017
- Hepatitis B virus genotypes and unique recombinants circulating among outpatients in selected hospitals in KenyaInternational Journal of Infectious Diseases, 2016
- Hepatitis B virus intergenotypic recombinants worldwide: An overviewInfection, Genetics and Evolution, 2015
- Hepatitis B virus subgenotype A1, occurrence of subgenotype D4, and S gene mutations among voluntary blood donors in KenyaVirus Genes, 2013
- Genotyping and molecular characterization of hepatitis B virus in liver disease patients in KenyaInfection, Genetics and Evolution, 2013
- Molecular characterization of hepatitis B virus and a 9‐year clinical profile in a patient infected with genotype IJournal of Medical Virology, 2010
- Basic local alignment search toolJournal of Molecular Biology, 1990